CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?

Volume 75, Issue 16, April 2020

JOURNAL:JACC Article Link

2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)

GJ Dehmer, V Badhwar, EA Bermude et al. Keywords: ACC/AHA Clinical Data Standards; ACS; CHD; PCI; CABG; coronary revascularization; clinical trials

Full Text PDF